Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study

Similar Items

• Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study
  od: Kawai, Takashi, i dr.
  Izdano: (2018)
• Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
  od: Ashida, Kiyoshi, i dr.
  Izdano: (2018)
• Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
  od: Sugano, Kentaro, i dr.
  Izdano: (2012)
• Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
  od: Ashida, K., i dr.
  Izdano: (2015)
• Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis
  od: Xiao, Yinglian, i dr.
  Izdano: (2020)